The study evaluated the safety and tolerability of felzalutamab in adults who experienced late AMR at least six months after kidney transplantation. Credit: mi_viri / Shutterstock.com Human Immunology Biosciences (HI-Bio) …
Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.
Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.
Copyright ©️ 2024 Daily Transplant News | All rights reserved.
